Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Richards, Elizabeth C."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Trevejo, Jose M., Marino, Michael W., Philpott, Nicola, Josien, Regis, Richards, Elizabeth C., Elkon, Keith B., Falck-Pedersen, Erik
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2001 Oct 01. 98(21), 12162-12167.
Externí odkaz:
https://www.jstor.org/stable/3056866
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1996 Oct . 93(21), 11798-11801.
Externí odkaz:
https://www.jstor.org/stable/40516
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1995 Mar . 92(6), 2219-2223.
Externí odkaz:
https://www.jstor.org/stable/2366964
Autor:
Jaya M. Satagopan, Richards Elizabeth C, Raymond E. Baser, Kenneth Cheung, Denise D. Correa, Sasan Karimi, Michael T. Lin, Lisa M. DeAngelis, John K. Lyo, Irene Orlow
Publikováno v:
Neurology. 83:320-327
Objective: The goal of this study was to assess whether the APOE e4 allele and other APOE single nucleotide polymorphisms (SNPs) influence neuropsychological and neuroimaging outcomes in patients with brain tumors. Methods: Two hundred eleven patient
Autor:
Ronald D. Finn, P. M. Deckert, Richards Elizabeth C, Nicholas J. Montalto, M. A. Clark, C. Williams, Sydney Welt, Achim A. Jungbluth, Katherine S. Panageas, L. J. Old
Publikováno v:
International Journal of Cancer. 87:382-390
Therapeutic proteins have been conjugated with polyethylene glycol (PEGylation) to reduce immunogenicity and enhance circulating dose. Here we have investigated the effect of PEGylation on immunogenicity, pharmacokinetics, and histologic microdistrib
Autor:
Richards Elizabeth C, Lloyd J. Old, Ashley R. Dunn, Hisashi Wada, Melissa Inglese, Yuji Noguchi, Michael W. Marino, Achim A. Jungbluth, Dianne Grail, Barbara Williamson, Sunanda Basu, Malcolm A.S. Moore
Publikováno v:
Proceedings of the National Academy of Sciences. 94:8093-8098
Although tumor necrosis factor (TNF) initially came to prominence because of its anti-tumor activity, most attention is now focused on its proinflammatory actions. TNF appears to play a critical role in both early and late events involved in inflamma
Autor:
J S Germain, L. J. Old, Nancy E. Kemeny, Ronald D. Finn, Chaitanya R. Divgi, Andrew M. Scott, Farhad Daghighian, Steven M. Larson, Richards Elizabeth C, Sydney Welt
Publikováno v:
Journal of Clinical Oncology. 14:1787-1797
PURPOSE A phase I/II study was designed to determine the maximum-tolerated dose (MTD) of iodine 125-labeled monoclonal antibody A33 (125I-mAb A33), its limiting organ toxicity, and the uptake and retention of radioactivity in tumor lesions. PATIENTS
Publikováno v:
Proceedings of the National Academy of Sciences. 92:2219-2223
BALB/c murine sarcoma Meth A is known to have three missense point mutations in p53. We previously reported that a nonamer peptide containing the codon 234 mutational product (designated 234CM) elicited 234CM-specific cytotoxic T cells and that immun